[ 22 ] showed a decreasing trend in the prevalence of hepatitis C among high-risk groups (β = − 0.021) in 2000–2015.
← all excerpts
Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.
1
—
—